Intra-Cellular Therapies, Inc. Quarterly Return On Assets in % from Q4 2013 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Return On Assets history and growth rate from Q4 2013 to Q2 2024.
  • Intra-Cellular Therapies, Inc. Return On Assets for the quarter ending June 30, 2024 was -9.6 %, a 61.3% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Return On Assets for 2023 was -19.4 %, a 39.1% increase from 2022.
  • Intra-Cellular Therapies, Inc. annual Return On Assets for 2022 was -31.9 %, a 34.2% increase from 2021.
  • Intra-Cellular Therapies, Inc. annual Return On Assets for 2021 was -48.4 %, a 28.6% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -9.6 +15.2 +61.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -15.3 +14.5 +48.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -19.4 +12.5 +39.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -21.3 +19 +47.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -24.8 +22.3 +47.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -29.7 +18.1 +37.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -31.9 +16.6 +34.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -40.4 -0.11 -0.27% Jul 1, 2022 Sep 30, 2022
Q2 2022 -47.1 -13.1 -38.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -47.8 -12.1 -33.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -48.4 -10.8 -28.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -40.3 +2.3 +5.41% Jul 1, 2021 Sep 30, 2021
Q2 2021 -34.1 +17.3 +33.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -35.7 +12.8 +26.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -37.7 +12.2 +24.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -42.6 +3.28 +7.16% Jul 1, 2020 Sep 30, 2020
Q2 2020 -51.3 -7.03 -15.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -48.5 -7.22 -17.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -49.9 -11.1 -28.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -45.8 -12.1 -35.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -44.3 -14 -46.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 -41.3 -14.7 -55.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 -38.8 -13.2 -51.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -33.7 -7.41 -28.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -30.3 -5.5 -22.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -26.6 -0.18 -0.68% Jan 1, 2018 Mar 31, 2018
Q4 2017 -25.6 -0.33 -1.31% Oct 1, 2017 Dec 31, 2017
Q3 2017 -26.3 -2 -8.23% Jul 1, 2017 Sep 30, 2017
Q2 2017 -24.8 +0.3 +1.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -26.4 -0.02 -0.08% Jan 1, 2017 Mar 31, 2017
Q4 2016 -25.3 +3.68 +12.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -24.3 +9 +27% Jul 1, 2016 Sep 30, 2016
Q2 2016 -25.1 +11.3 +31.1% Apr 1, 2016 Jun 30, 2016
Q1 2016 -26.4 +3.57 +11.9% Jan 1, 2016 Mar 31, 2016
Q4 2015 -29 -6.9 -31.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -33.3 -13 -64.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -36.4 -12.8 -54.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -29.9 +14.4 +32.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -22.1 +103 +82.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -20.3 Jul 1, 2014 Sep 30, 2014
Q2 2014 -23.6 Apr 1, 2014 Jun 30, 2014
Q1 2014 -44.4 Jan 1, 2014 Mar 31, 2014
Q4 2013 -125 Oct 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.